Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
06/2003
06/05/2003US20030104620 Expression vector for expression of heterologous polypeptides and amplification of cell viral resistance; viricides
06/05/2003US20030104612 Generation of type I/type II hybrid form of bovine viral diarrhea virus for use as vaccine
06/05/2003US20030104582 Oligonucleotides and methods for detecting hepatitis C viral nucleic acids
06/05/2003US20030104570 Triple fusion proteins comprising ubiquitin fused between thioredoxin and a polypeptide of interest
06/05/2003US20030104569 Proteins suppressing proliferation of lympho-hematopoietic cells
06/05/2003US20030104530 Inhibiting competetive binding; maintenance of organelle equilibrium; drug resistance
06/05/2003US20030104528 Lymphocytes; transcription factors; interferons
06/05/2003US20030104516 Protein kinase npk-110
06/05/2003US20030104500 Enzymatic assays for screening anti-cancer agents
06/05/2003US20030104485 Antibodies specific for osteoprotegerin binding proteins and method of use
06/05/2003US20030104455 Methods and compositions for treating urological disorders using 313, 333, 5464, 18817 or 33524
06/05/2003US20030104419 Method of classifying a thyroid carcinoma using differential gene expression
06/05/2003US20030104366 Polypeptides for use in the diagnosis and prevention of tumors; antiproliferative agents
06/05/2003US20030104356 Compounds and methods for treating and screening viral reactivation
06/05/2003US20030104077 Relieving symptoms of erectile dysfunction with proanthocyanidins
06/05/2003US20030104067 Method of obtaining cellular immune responses from proteins
06/05/2003US20030104045 Novel therapeutic binding molecule complexes
06/05/2003US20030104044 Nucleic acid polymer encapsulated in a lipid cationic lipid particle
06/05/2003US20030104014 Method for the treatment of malignant and infectious chronic diseases
06/05/2003US20030104013 Inhibitor of histamine synthesis, especially of of histidine decarboxylase such as tritoqualine; allergen, e.g., cysteine protease
06/05/2003US20030104012 Vaccines for the treatment of autoimmune disease
06/05/2003US20030104011 Inactivated reverse transcriptase.
06/05/2003US20030104010 Novel, non-antigenic, mucosal adjuvant formulation which modulates the effects of substances, including vaccine antigens, in contact with mucosal body surfaces
06/05/2003US20030104009 Retrovirus isolated from mantle histiocytes in mantle cell lymphoma
06/05/2003US20030104008 In vivo and in vitro expression vectors comprising and expressing at least one polynucleotide of West Nile fever virus, as well as immunogenic compositions and vaccines against West Nile fever
06/05/2003US20030104003 Novel surface protein of the malaria parasite plasmodium falciparum
06/05/2003US20030104002 Antigenic iron repressible proteins from N. meningitidis related to the hemolysin family of toxins
06/05/2003US20030104000 Peptide encoded by gene identified herein as pho2-2, obtainable from Group B Streptococcus, or a homologue or a functional fragment thereof; neonatal infections, urinary tract infections
06/05/2003US20030103999 Novel therapeutic compositions for treating infection by Lawsonia spp.
06/05/2003US20030103996 Containing complex comprising an antigen of a microbial or molecular pathogen and mammalian cell constituents in isolated or purified form
06/05/2003US20030103995 Detection and therapy of vulnerable plaque with photodynamic compounds
06/05/2003US20030103994 Comprising lung tumor polypeptides or immunogenic portions thereof, polynucleotides that encode such polypeptides, antigen presenting cells that expresses such polypeptides, T cells specific for cells expressing such polypeptides
06/05/2003US20030103992 Cadherin-like asymmetry proteins, in particular, polynucleotides, polypeptides, fusion proteins, and antibodies; for modulating immune response
06/05/2003US20030103991 For serodiagnosing ehrlichiosis in mammals, particularly in members of the Canidae family and in humans
06/05/2003US20030103990 Composition for inducing humoral anergy to an immunogen comprising a T cell epitope-deficient analog of the immunogen conjugated to a nonimmunogenic valency platform molecule
06/05/2003US20030103989 Immunising pregnant mammal with antigen by any two routes of administration selected from intramammary, intraperitoneal and intramuscular and immunising mammal with antigen by third administration route, all three routes being different
06/05/2003US20030103988 Regulation of activated t cells by recognition of t cell receptor beta chains and major histocompatibility complex class ib molecules
06/05/2003US20030103986 TACI-immunoglobulin fusion proteins
06/05/2003US20030103984 Fusion proteins of biologically active peptides and antibodies
06/05/2003US20030103982 Therapeutic using a bispecific antibody
06/05/2003US20030103978 Antibodies and antigen binding domains used to prevent or treat conditions relating to loss of bone mass and bone disorders; nucleic acid encoding antibodies and antigen binding domains
06/05/2003US20030103977 Monoclonal antibodies binds to protective epitopes on serotype A, B, C and D strains of Cryptococcal; therapeutic treatment and prevent cryptococcal infection, such as cryptococcal meningitis, in immunosuppressed patients
06/05/2003US20030103974 Administering an antibodies or enzyme inhibitor of prothrombinase; therapeutic treatment of bacterial and viral infections, allograft and xenograft rejection, cancer, glomerulonephritis, gastrointestinal disorders and fetal loss
06/05/2003US20030103973 Method for reducing tumor growth with VEGF antagonists combined with radiation and chemotherapy
06/05/2003US20030103971 Immunoregulatory antibodies and uses thereof
06/05/2003US20030103969 Therapeutic treatment using an anti-CD14 antibody
06/05/2003US20030103966 Therapeutic treatment of asthma with anti-allergen antibody
06/05/2003US20030103964 Methods for designing molecular conjugates and compositions thereof
06/05/2003US20030103963 Complementary determining regions capable binding to the same antigen as the monoclonal antibody 8H9; inhibit competitive binding; isolated scFv of monoclonal antibody 8H9, antigen, antitumor agents
06/05/2003US20030103962 Methods and compositions for modulating the immune system of animals
06/05/2003US20030103948 Streptavidin expressed gene fusions and methods of use thereof
06/05/2003US20030103938 Pharmaceutical compositions for preventing or treating Th1 and Th2 cell related diseases by modulating the Th1/Th2 ratio
06/05/2003US20030103937 Comprises interleukins for enhancing engraphment of bone marrow during transplantation; for treating allergies and blood disorders
06/05/2003US20030103903 Detecting nut allergy
06/05/2003CA2852277A1 Simian adenovirus nucleic acid and amino acid sequences, vectors containing same, and methods of use
06/05/2003CA2486924A1 Use of t-cell immune response cdna 7 (tirc7) for modulation of angiogenesis and/or neovascularization
06/05/2003CA2468878A1 Antigen presenting cell targeting conjugate, an antigen presenting cell contacted with such conjugate, their use for vaccination or as medicament, and methods for their productionor generation
06/05/2003CA2468718A1 Fusion proteins containing tlp peptides
06/05/2003CA2468511A1 A method for combined sequential agent delivery and electroporation for cell structures and use thereof
06/05/2003CA2468501A1 T-cell epitodes in carboxypeptidase g2
06/05/2003CA2468424A1 A method for combined parallel agent delivery and electroporation for cell structures and use thereof
06/05/2003CA2468320A1 Methods for treating cancer using a combination of a tumor-derived dendritic cell inhibitory factor antagonist and a toll-like receptor agonist
06/05/2003CA2468020A1 Osteopontin-related compositions and methods
06/05/2003CA2468016A1 Humanized collagen antibodies and related methods
06/05/2003CA2467831A1 Mint extract and related pharmaceutical compositions
06/05/2003CA2467647A1 Therapeutic use of antibodies and fragments thereof binding primate ifn-gamma
06/05/2003CA2467645A1 Composition for removing fibrin-bound blood clots from a catheter
06/05/2003CA2467397A1 Flavivirus vaccine delivery system
06/05/2003CA2466931A1 Antagonist anti-cd40 monoclonal antibody therapy for multiple sclerosis treatment
06/05/2003CA2466845A1 Manipulation of cytokine levels using cd83 gene products
06/05/2003CA2466841A1 Synthetic immunogenic but non-deposit-forming polypeptides and peptides homologous to amyloid .beta., prion protein, amylin, .alpha.-synuclein, or polyglutamine repeats for induction of an immune response thereto
06/05/2003CA2466431A1 Simian adenovirus nucleic acid and amino acid sequences, vectors containing same, and methods of use
06/05/2003CA2465072A1 Treatment of micro-organism infection
06/05/2003CA2454397A1 Attenuated rabies virus with nucleoprotein mutation at the phosphorylation site for vaccination against rabies and gene therapy in the cns
06/05/2003CA2435758A1 Polynucleotide therapy_against autoantigens for treating insulin dependent diabetes mellitus
06/04/2003EP1316560A1 Novel human cancer/testis antigen and gene thereof
06/04/2003EP1316314A1 Vaccine preparation containing fatty acid as component
06/04/2003EP1315965A2 Methods and compositions for in vitro targeting
06/04/2003EP1315840A2 Biopanning and rapid analysis of selective interactive ligands (brasil)
06/04/2003EP1315830A2 Compositions and methods for targeting peptides in humans in vivo
06/04/2003EP1315817A2 18431 and 32374, human protein kinase family members and uses therefor
06/04/2003EP1315816A2 Genetically engineered co-expression dna vaccines, construction methods and uses thereof
06/04/2003EP1315812A2 Modified polypeptides stabilized in a desired conformation and methods for producing same
06/04/2003EP1315799A2 Attenuated hiv strains and use thereof
06/04/2003EP1315743A2 Mammalian genes; related reagents and methods
06/04/2003EP1315672A1 Delivery vehicle composition and methods for delivering antigens and other drugs
06/04/2003EP1315520A2 Use of trifunctional bispecific and trispecific antibodies for the treatment of malignant ascites
06/04/2003EP1315519A2 Pharmaceutical compositions and methods useful for modulating angiogenesis
06/04/2003EP1315518A2 Vaccine against microbial pathogens
06/04/2003EP1315517A1 Mimetic peptides for epitope of apolipoprotein b-100, concatemer and modified peptides thereof, and the vaccine composition comprising the same
06/04/2003EP1315512A2 Adenoviral targeting and manipulation of immune system response using targeting peptides
06/04/2003EP1315501A1 Alpha v integrin receptor antagonists
06/04/2003EP1315493A1 2-3-disubstituted quinuclidines as modulators of monoamine transporters and therapeutic and diagnostic methods based thereon
06/04/2003EP1315486A2 Antitumor combination comprising an aromatase inhibitor and an egfr antagonist or inhibitor
06/04/2003EP1143997B1 Tumor necrosis factor antagonists and their use in endometriosis treatment
06/04/2003EP1143934B1 Genetic immunization with co-delivery of nucleic acid and cytokines
06/04/2003EP0848752B1 Method for purifying viruses by chromatography
06/04/2003EP0692028B1 Pharmaceuticals based on papillomaviruses
06/04/2003EP0679189B1 Cloning of enterokinase and method of use
06/04/2003EP0672116B1 Deletion mutants as vaccines for cholera
1 ... 1241 1242 1243 1244 1245 1246 1247 1248 1249 1250 1251 1252 1253 1254 1255 1256 1257 1258 1259 1260 1261 ... 1823